Latest Ai Platforms News

Page 13 of 15
Opyl Limited’s AI platform TrialKey has partnered with UK insurer Innovatrix to launch a pioneering parametric insurance product that protects biotech firms from the financial risks of clinical trial failures.
Ada Torres
Ada Torres
18 June 2025
Harvest Technology Group reports it is one year ahead of its 3-Year Pathway to Profit plan, forecasting a significant reduction in EBITDA loss for FY25 and unveiling plans for its AI-powered NEON platform launch in 1H26.
Sophie Babbage
Sophie Babbage
17 June 2025
Opyl Limited has secured strategic collaborations with two leading contract research organisations, integrating its AI-driven TrialKey platform into cardiovascular, oncology, and rare disease clinical trials to enhance trial design and accelerate commercial growth.
Ada Torres
Ada Torres
12 June 2025
Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.
Ada Torres
Ada Torres
10 June 2025
Algorae Pharmaceuticals has secured a significant A$318,771 R&D tax incentive rebate from the Australian Taxation Office, providing a non-dilutive cash injection to advance its AI-driven drug discovery programs.
Ada Torres
Ada Torres
6 June 2025
Nanoveu’s subsidiary EMASS has hit a key milestone with its ECS-DoT chip achieving 50 updates per second in drone flight simulations, enabling smarter, more stable drones with up to 30% longer flight times.
Sophie Babbage
Sophie Babbage
30 May 2025
Straker Ltd reports a solid FY25 performance marked by a strategic shift from legacy translation services to AI-powered language verification, underpinned by robust cash reserves and improved profitability.
Sophie Babbage
Sophie Babbage
27 May 2025
Smart Parking Limited reports robust H1 FY25 growth driven by a strategic US acquisition and expanding global footprint, underpinned by proprietary AI technology.
Sophie Babbage
Sophie Babbage
21 May 2025
Vection Technologies has secured a strategic partnership with Area 12 Consulting, guaranteeing $0.5 million in annual recurring revenue for its Algho AI platform. This deal marks a significant step in expanding Vection's footprint in the generative AI and digital transformation space.
Sophie Babbage
Sophie Babbage
12 May 2025
Algorae Pharmaceuticals has partnered with Peter MacCallum Cancer Centre to validate AI-predicted drug combinations across multiple cancer types, aiming to accelerate its oncology pipeline development.
Ada Torres
Ada Torres
8 May 2025
Opyl Limited has successfully raised $1.5 million through an oversubscribed placement to accelerate the growth of its AI-driven clinical trial platform, Trialkey. The capital injection underscores strong investor confidence as the company prepares for a pivotal expansion phase.
Ada Torres
Ada Torres
2 May 2025
InteliCare Holdings has secured a new commercial trial with mecwacare and advanced deployments at Hardi Aged Care sites, underpinning growth in its AI-driven aged care platform amid regulatory changes.
Victor Sage
Victor Sage
30 Apr 2025